ml 190

ML 190 is a potent and selective κ opioid receptor (KOR) antagonist (Ki=129 nM), exhibiting an IC50=150 nM in β-arrestin assays, suitable for studying drug addiction.

BML-190 (Indomethacin morpholinylamide) is a specific CB2 receptor inverse agonist (Ki: 435 nM), with 50-fold selectivity over CB1 receptor.

NC190 is an inhibitor of topoisomerase II that inhibited the growth of FM3A cells in clinical trials. NC-190 strongly inhibited the growth of FM3A cells when cultured with NC-190 for 48 h (IC50: 0.019 μg/ml). NC-190 potently suppressed DNA synthesis with

L-Ascorbic acid 6-stearate, a compound derived from L-ascorbic acid and stearic acid identified in K. coccinea, exhibits antioxidant and anticancer properties. It effectively scavenges DPPH radicals in cell-free assays (IC50 = 3.31 µg/ml). Additionally, lipid nanoparticles (LNPs) containing L-ascorbic acid 6-stearate have been shown to trigger apoptosis in HL-60 promyeloblasts at a concentration of 190 µM. This compound is also incorporated into cosmetic and personal care product formulations due to its beneficial effects.

L-Ascorbic Acid 6-stearate (Standard) is the standard substance of L-Ascorbic Acid 6-stearate, and it is applicable for quantitative analysis, quality control, and related research in biochemical experiments. L-Ascorbic acid 6-stearate, a compound derived from L-ascorbic acid and stearic acid identified in K. coccinea, exhibits antioxidant and anticancer properties. It effectively scavenges DPPH radicals in cell-free assays (IC50 = 3.31 µg/ml). Additionally, lipid nanoparticles (LNPs) containing L-ascorbic acid 6-stearate have been shown to trigger apoptosis in HL-60 promyeloblasts at a concentration of 190 µM. This compound is also incorporated into cosmetic and personal care product formulations due to its beneficial effects.